BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gandhi P, Shrivastava R, Garg N, Sorte SK. Novel molecular panel for evaluating systemic inflammation and survival in therapy naïve glioma patients . World J Clin Oncol 2021; 12(10): 947-959 [PMID: 34733616 DOI: 10.5306/wjco.v12.i10.947]
URL: https://www.wjgnet.com/2218-4333/full/v12/i10/947.htm
Number Citing Articles
1
Michael Goutnik, Brandon Lucke-Wold. Commentary: Evaluating potential glioma serum biomarkers, with future applicationsWorld Journal of Clinical Oncology 2022; 13(5): 412-416 doi: 10.5306/wjco.v13.i5.412
2
Rongxuan Hua, Qiuxuan Li, Han Gao, Boya Wang, Chengwei He, Ying Wang, Sitian Zhang, Lei Gao, Hongwei Shang, Wen Wang, Jingdong Xu. Association of human telomerase reverse transcriptase promoter mutation with unfavorable prognosis in glioma: A systematic review and meta-analysisJournal of Research in Medical Sciences 2023; 28(1): 47 doi: 10.4103/jrms.jrms_371_22
3
Richa Shrivastava, Puneet Gandhi, Ragini Gothalwal. The road-map for establishment of a prognostic molecular marker panel in glioma using liquid biopsy: current status and future directionsClinical and Translational Oncology 2022; 24(9): 1702 doi: 10.1007/s12094-022-02833-8